Congratulations to the Relation team for securing this landmark partnership deal with GSK. We're delighted and proud to be a founder investor in this great company. Onward! The Times - https://lnkd.in/encyZrqt Newswire - https://lnkd.in/eRTeaM_u Endpoint - https://lnkd.in/eCCFwKYs
💥 📡 *BREAKING NEWS* 📡 💥 ⭐ We are thrilled to announce a landmark double collaboration with GSK to advance the understanding and treatment of fibrosis and osteoarthritis ⭐ 🤖🧬🦾 Together, we’re combining cutting-edge biology, advanced machine learning, and our unique Lab-in-the-Loop platform to identify and validate new drug targets with precision. ✳️ This collaboration reflects the power of integrating human genetics, multiomics, and innovative analytics to address areas of significant unmet need and drive transformative impact for patients. 🔊 Read more: ➡️ The Times article by Alex Ralph https://lnkd.in/eDbU9_F4 📰 Press release here https://lnkd.in/ezy9Vzmu ⬇️ Endpoints News coverage by Kyle LaHucik David Roblin Casey Benjamin Swerner Edith Hessel Lindsay Edwards Jake P. Taylor-King Charles Campbell Roberts Rosie Rodriguez PhD Kaivan Khavandi Chris Sheldon, PhD Tony Wood #cause2cure #thepatientiswaiting #ml #drugdiscovery #gsk #relation https://lnkd.in/e2XjMj6Q
